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An understanding of host–parasite interplay is essential for the development of therapeutics and
vaccines. Immunoparasitologists have learned a great deal from ‘conventional’ in vitro and in vivo
approaches, but recent developments in imaging technologies have provided us (immunologists and
parasitologists) with the ability to ask new and exciting questions about the dynamic nature of the par-
asite–immune system interface. These studies are providing us with new insights into the mechanisms
involved in the initiation of a Leishmania infection and the consequent induction and regulation of the
immune response. Here, we review some of the recent developments and discuss how these observations
can be further developed to understand the immunology of cutaneous Leishmania infection in vivo.
 2010 Elsevier Inc. Open access under CC BY license. 1. Introduction
Leishmania infections present a major global health challenge,
with an estimated 12 million people infected worldwide and con-
sequently there is an urgent need for better prophylactic and ther-
apeutic interventions for this disease (Mansueto et al., 2007). The
induction of an immune response requires a series of complex
interactions between several different cell types (and their prod-
ucts), with an orchestra of secreted proteins, surface receptors,
signalling pathways and intracellular processes occurring in a
highly specialised manner (Guermonprez et al., 2002). Importantly,
relatively small changes in only a few of these cell–cell or protein–
protein interactions can dramatically alter the functional charac-
teristics of the immune response generated (Gett et al., 2003),
and can dictate whether an infection is controlled or establishes
a chronic, progressive disease in the host. Leishmania is of particu-
lar interest in this regard since it is a major global health challenge
in its own right, but relatively few differences between individual
species (e.g. Leishmania major versus Leishmania donovani versus
Leishmania braziliensis), or the genetic background and/or immuno-
logical status of the host can result in signiﬁcantly different out-
comes (cutaneous versus visceral, chronic versus healing) (Ivens
et al., 2005; McMahon-Pratt and Alexander, 2004; Peacock et al.,
2007; Sacks and Noben-Trauth, 2002). Hence, in order to develop
novel therapeutics and vaccine strategies, an improved under-ics, Strathclyde Institute of
rathclyde, 27 Taylor Street,
R. Millington).
 license. standing of the underlying immunology is needed. The wide spec-
trum of human disease can be mimicked in murine models and
these have been used extensively for than conventional imaging
in vitro studies to dissect host cell/parasite interactions, as well
as in vivo to elucidate the complex nature of the immunological
process involved. Critically, the complex nature of the immune sys-
tem necessitates the use of in vivo models of infection in order to
elucidate the precise roles of the speciﬁc interactions involved.
Typically, the study of Leishmania infections in the mouse has
used approaches such as parasite-speciﬁc immunoglobulins, mea-
surement of lesion size, parasite burden and in vitro recall re-
sponses of lymph node or spleen cells to understand the
fundamental immunology of infection. As novel techniques devel-
oped allowing in-depth analysis of the speciﬁc cells of the immune
system, immunoparasitologists have embraced these approaches
to better understand the kinetics of Leishmania infection.
Thus, ﬂow cytometric analysis has been used to investigate
many aspects of Leishmania infection, such as the role of CC chemo-
kine receptor-2 in the migration of skin-derived dendritic cells
(DCs) to the lymph node, antigen presentation by tissue-derived
versus lymph node-resident DCs, as well as to examine the kinetics
of cell recruitment back into the lesion (Belkaid et al., 2000; Iezzi
et al., 2006; Sato et al., 2000). Others used immunohistochemical
and immunoﬂuorescence staining of sections taken at different
times following Leishmania infection to establish the distinct path-
ways involved in mediating immunity, migration and disease
regulation (Ato et al., 2006). However, recent advances in imaging
systems have provided the opportunity to further understand the
development of infection and the induction of an immune
response against and its modulation by the parasite.
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Ever since van Leeuwenhoek developed his simple microscope
and observed protozoa in droplets of water, researchers have been
fascinated with the possibility of visualising the interactions of
parasites and the immune system. The use of ﬂuorescence- or
luminescence-based imaging approaches has allowed immunopar-
asitologists to characterise many of the fundamental processes in-
volved in Leishmania infection. Whilst the use of green ﬂuorescent
protein (GFP) and other ﬂuorochromes has expedited the use of
ﬂuorescence microscopy, the development of imaging systems
allowing users to look across a variety of scales (from full animal
imaging down to the sub-micron resolution) has been of critical
importance. There have been several recent developments provid-
ing novel approaches to assess cell–cell or protein–protein interac-
tions, visualise single molecules and offer imaging beyond the
diffraction limit.2.1. Bioluminescence
In vivo bioluminescence imaging was ﬁrst used to monitor
infection in a Salmonella typhimurium model (Contag et al., 1995).
By introducing ﬁreﬂy or Renilla luciferase into pathogens or cells
of interest their in vivo localisation and proliferation or clearance
can be assessed. Interaction between the luciferase enzyme and
its substrate (luciferin) results in emission of photons, which can
then be detected using a high sensitivity cooled charge-coupled
device (CCCD) camera. This approach allows whole-body imaging
of small animals and researchers are able to localise the signal by
overlaying a map of speciﬁc tissues and organs. Indeed, some bio-
luminescence imaging systems now include an integrated X-ray
system to provide further locational detail (Andreev et al., 2007;
Backer et al., 2007). However, signiﬁcant absorption of light by
body tissues means that these approaches rely on a relatively
strong signal, requiring a minimum of 103–104 reporter cells to
generate sufﬁcient signal for detection (around 20 pg of luciferase
(Lang et al., 2005; Rettig et al., 2006)). The recent development of
red-shifted luciferases will aid in this enhancing this sensitivity,
reducing the light absorption by tissue (Loening et al., 2007; Shapiro
et al., 2005). Also, whilst these systems provide somemagniﬁcation
capability, (typically resolving down to sub-millimetre resolution),
their resolution and sensitivity does not provide the opportunity
for analysing the behaviour of single cells or small populations of
cells. A major disadvantage of bioluminescent proteins is their
requirement for available substrate. This is especially problematic
for long term in vivo experimentswhere continuous injectionof sub-
strate would be needed. Furthermore, non-homogenous distribu-
tion of substrate in vivo differs depending on the route of substrate
administrationand complicates the accurate localisationof biolumi-
nescent cells or pathogens (Claes et al., 2009).2.2. Fluorescence microscopy
Unlike bioluminescence (where an enzymatic reaction gener-
ates emitted photons), ﬂuorescence microscopy introduces illumi-
nation of one wavelength to excite a ﬂuorescent molecule and then
detects photons emitted at a red-shifted wavelength as the excited
electrons decay back to their ground state. Several advances in
ﬂuorescent microscopy have provided researchers with a wide
range of facilities for imaging, depending on the needs of the user.
Epi-ﬂuorescence microscopy provides an excellent introduction
to imaging, using relatively broad excitation and detection systems
to capture emissions from much of the depth of the sample. Whilst
this provides the opportunity to visualise cells and parasites with
good lateral resolution (e.g. Kupfer et al. (1986), Monks et al.(1998)), there is little control over the focal plane examined and
deconvolution is often required for effective 3-dimensional analy-
sis. Using confocal microscopy allows researchers to image in 3 and
4 dimensions with much more precision. By using a pinhole to re-
strict light collection to a single focal plane provides much greater
axial resolution and provides the opportunity to resolve images
down to the sub-micron level. For example, confocal microscopy
has been used to provide high-resolution images of Leishmania-
containing phagosomes to assess the localisation of MHC mole-
cules (Flohe et al., 1997; Lang et al., 1994), actin polymerisation
(Holm et al., 2001) and disruption of lipid rafts (Chakraborty
et al., 2005). However, relatively high laser intensities are required
for these imaging approaches, which can result in damage to bio-
logical samples and photobleaching above and below the focal
point. The spinning disk confocal microscope permits higher speed
imaging and is associated with less tissue damage, providing the
opportunity for in vivo imaging of ﬂuorescent samples. Whilst
these systems have been used to image cells of the immune system
with some success (e.g. Pﬂicke and Sixt (2009)), an inherent prob-
lem with confocal imaging systems is the limited depth penetra-
tion associated with light scattering by the tissue (especially at
lower wavelengths).
An important development was that of multiphoton laser-scan-
ning microscopy (MPLSM; (Squirrell et al., 1999)). This provides
the 3 and 4-dimensional analysis of confocal imaging approaches,
but rather than exciting ﬂuorescence throughout the depth of the
tissue, the laser excitation is focused to a very tight point. Impor-
tantly, ﬂuorophores are stimulated by the near-simultaneous exci-
tation of two higher wavelength photons (as opposed to a single
lower wavelength photon in confocal imaging) (Squirrell et al.,
1999). This allows imaging of ﬂuorescent samples at depths in
the order of hundreds of microns within the tissue, with relatively
little damage to surrounding tissues. However, this approach often
requires removal (or surgical exposure) of the tissue of interest,
with limited possibility for repeated imaging. Also, the relatively
small ﬁeld-of-view restricts the area of imaging to a few hundred
microns across and whilst MPLSM is able to probe deeper into tis-
sue than previous approaches, organs of interest can be much
thicker than light penetration allows.
Whilst these approaches have proved incredibly useful in terms
of understanding the host–parasite interaction of Leishmania infec-
tion, it is important to understand some of the problems associated
with these imaging approaches. For example, bioluminescence
imaging of luciferase-expressing parasites requires efﬁcient uptake
and delivery of the luciferin substrate to parasites contained within
the parasitophorous vacuole. In addition, the acidic pH of the par-
asitophorous vacuole may alter the emission spectra of certain ﬂu-
orochromes (Tsien, 1998). The Leishmania life cycle is complex, and
certain stages may be associated with rearrangement of proteins,
resulting reporter ﬂuorochromes localising to different compart-
ments in promastigotes and amastigotes. For example, we have
generated Leishmania mexicana parasites expressing Ea-DSRed
and Ea-mCherry with either a HASPB or HASPB G/A mutant signal
sequence to localise the ﬂuorochromes to the parasite membrane
or to retain the protein in the cytosol (Fig. 1). In these parasites,
stage-speciﬁc differences can be observed in terms of the localisa-
tion of the ﬂuorochromes, with DsRed correctly targeting to the
cytosol of promastigotes, but localising in lysosomes/megasomes
during amastigote stages (Fig. 1b). Interestingly, differences be-
tween in the membrane targeting of tetrameric DSRed and mono-
meric mCherry are also evident (Fig. 1a–d), demonstrating the
importance of appropriate ﬂuorochrome selection. In addition,
over-expression of ﬂuorescent/bioluminescence reporter proteins
may inﬂuence parasite ﬁtness, with EGFP-expressing L. mexicana
showing delayed lesion development compared with wild-type
parasites (Bennett et al., 2001).
Fig. 1. Imaging of Leishmania mexicana expressing red ﬂuorescent proteins. Ea-DSRed (a + b) or Ea-mCherry (c + d) were fused to the HASPB or HASPB G/A mutant signal
sequence to direct fusion proteins to the surface or cytosol of L. mexicana parasites (Denny et al., 2000; Prickett et al., 2006). Live promastigotes (left) or lesion-derived
amastigotes (right) were imaged on a Deltavision epiﬂuorescent microscope. (a) Tetrameric DSRed fused to HASPB signal is not detected on the surface of promastigotes or
lesion-derived amastigotes and appears to mislocalise to the lysosome. (b) DSRed fused to HASPB G/A is visible in the cytosol of promastigotes but appears to localise to large
lysosomes/megasomes in amastigotes. (c) The monomeric protein, mCherry, fused to HASPB is expressed on the promastigote surface but appears to locate to lysosomes/
megasomes in amastigotes. (d)mCherry fused to HASPB G/A is expressed in the cytosol of both promastigotes and lesion-derived amastigotes. Kinetoplast DNA (blue) is stained
with DAPI. Corresponding brightﬁeld images are shown on the right of each epiﬂuorescent image. Scale bar = 5 lm. (e) Stationary-phase L. mexicana promastigotes expressing
Ea-mCherry fused to the HASPB G/A mutant signal were injected into right hind footpads of BALB/c mice. Disease progression was monitored by in vivo ﬂuorescence imaging
using a Xenogen IVIS Spectrum. The Region of Interest (ROI) indicates ﬂuorescence measured in the footpad at each time point after infection. Fluorescence increased over time
and corresponded to an increase in lesion size and parasite load. Mice infected with wild-type L. mexicana (WT) showed background levels of ﬂuorescence while lesion size
progressed over time. (For interpretation of the references in colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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3.1. Visualising the complexity of intracellular infection
Early electron microscopy and ﬂuorescence studies of intracel-
lular Leishmania infection provided an insight into the complex
mechanisms of uptake and movement of parasite-containing vacu-
oles within an infected macrophage. Thus, it was demonstrated
that amastigotes reside in a phagolysosome but that a parasite-in-
duced manipulation of the process of phagosome fusion could en-
hance parasite growth (see Fig. 2a) (Alexander, 1981). These early
observations suggested a defect in phagosome–endosome fusion
following promastigote infection. Phagosomal development is typ-
ically associated with accumulation of F-actin, which is then re-
moved as the phagosome matures (Aderem and Underhill, 1999).
Using confocal microscopy to visualise GFP-expressing wild-type
and LPG-deﬁcient promastigotes, Holm et al. demonstrated that
LPG plays an important role in maintaining this periphagosomal
F-actin, which has been proposed to provide a physical barrier to
reduce phagosome–endosome fusion (Holm et al., 2001). More re-
cently, studies have used ﬂuorescence systems to assess the matu-
ration of parasite-containing phagosomes. Rab5 is a key regulator
of phagosome maturation, and using cells derived from GFP-Rab5
transgenic mice Lippuner et al. were able to assess whether L. mex-
icana are contained within Rab5+ compartments in macrophages
(Lippuner et al., 2009). Real-time ﬂuorescence imaging of these
cultures conclusively demonstrated that L. mexicana-containingFig. 2. The evolution of ﬂuorescence microscopy in studies of Leishmania. (a) Dark-ﬁeld vi
Lysosomes have fused to parasitophorous vacuoles, some containing single parasites and
L. mexicana (green) internalised by a dendritic cell (stained with cholera toxin subunit B
were co-cultured for 1 h to allow internalization of the parasite prior to ﬁxation and imag
imaging the ear of a CD11c-YFP mouse infected with mCherry-expressing L. mexicana.
parasites (red) in vivo. Using Volocity analysis software (Improvision), individual ce
square = 8 lm. (For interpretation of the references in colour in this ﬁgure legend, the rphagosomes were Rab5+ for much shorter times than other phago-
somes and that this was associated with LPG expression on the sur-
face of the parasite. This demonstrates the importance of analysing
these complex spatial and temporal cell–pathogen interactions
over a signiﬁcant period of time. Real et al. (2008) made use of
GFP-expressing Leishmania amazonensis parasites to show the fu-
sion of newly-formed parasite-containing phagosomes (or PV) to
pre-established PV’s containing unlabelled parasites (Real et al.,
2008). Their model may be useful for future studies on the parasite
or host factors that inﬂuence PV fusogenicity and maturation.
The use of ﬂuorescent parasites is also helping our understand-
ing of the fundamental biology of Leishmania infection (Fig. 2b).
Using transgenic L. amazonensis parasites expressing the DsRed2
ﬂuorescent protein, Lecoeur et al. (2009) investigated modulation
of dendritic cell gene expression by Leishmania. Several reports
have used ﬂuorescent parasites to investigate the effects of Leish-
mania upon dendritic cells (e.g. Bennett et al. (2001), Colmenares
et al. (2002), Gorak et al. (1998), Iezzi et al. (2006), Jebbari et al.
(2002), Maroof and Kaye (2008), Misslitz et al. (2004), Prina et al.
(2004), von Stebut et al. (1998), Williams (1988)), but puriﬁcation
of parasite-containing dendritic cells (based on ﬂuorescence) re-
vealed signiﬁcant modulation of transcription of several genes crit-
ical for DC function, which was not identiﬁed in the unsorted
population. Importantly, whilst epi-ﬂuorescence imaging was also
used to conﬁrm that the DsRed-positive cells contained ﬂuorescent
parasites, in the future it will be important to develop in situ
visualisation and puriﬁcation procedures to ensure that cells do
not acquire parasites during tissue processing. The use of thesetal ﬂuorescence staining of macrophage secondary lysosomes using acridine orange.
others multiple parasites. (b) Three-dimensional confocal imaging of GFP-expressing
-AF647 to reveal lipid rafts; red). GFP-expressing promastigotes and dendritic cells
ing. (c and d) In vivo imaging of dendritic cell/Leishmania interaction by multiphoton
The image shows a number of dendritic cells (yellow) interacting with ﬂuorescent
lls can be identiﬁed and false-coloured (d), allowing tracking over time. Grid
eader is referred to the web version of this article.)
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of great importance in the development of high-throughput
screening approaches currently under development.
3.2. Analysing Leishmania infection and cell recruitment in vivo
The complex and dynamic nature of the Leishmania infection site
necessitates in vivo studies to characterise the kinetics of the para-
site burden and the associated recruitment and function of key cells
of the immune system. Several ﬂuorescence-based approaches have
been employed to visualise, at a cellular level, the response to infec-
tion and the mechanisms involved (Fig. 2c and d). Recently, Rein-
hardt et al. (2009) have used ﬂuorescent reporter mice to analyse
the cytokine response to L. major infection. Using ﬂow cytometry
and immunoﬂuorescence in strains of micewhich reveal active pro-
duction of IL-4 and of IFNc they showed that, following L. major
infection, IL-4 release is essentially limited to B cell follicles and ger-
minal centres. Importantly, by isolating cell conjugates based on
ﬂuorescence-reporters of cytokine production, the authors demon-
strated that both the IL-4-producing and IFNc-producing follicular
helper T cells interactedwith B cells and speciﬁcally direct immuno-
globulin switching towards IgG1 and IgG2a, respectively.
Obviously, the changing environment of the Leishmania infec-
tion site necessitates an imaging modality that allows repeated
imaging sessions in order to monitor these changes. The develop-
ment of bioluminescent L. amazonensis provided a sensitive detec-
tion method to monitor growth over several weeks following
infection. Using luciferase-transfected parasites, Lang et al. moni-
tored parasite development at the site of intradermal inoculation
and in the draining lymph node, demonstrating that this approach
provides a highly sensitive method for detection and quantiﬁcation
of early infection (Lang et al., 2005). Importantly, this approach ne-
gated the need to sacriﬁce animals at regular time points following
infection, allowing repeated quantiﬁcation of parasite numbers in
the same animal over time. Recently, we have used mCherry-
expressing L. mexicana parasites to monitor development of cuta-
neous infection over time (Fig. 1e). Combinations of these ap-
proaches will allow researchers to visualise the recruitment of
speciﬁc cell types during infection, as has recently been investi-
gated in visceral leishmaniasis (Beattie et al., 2010).
3.3. Visualising the dynamic nature of cells of the immune system
during Leishmania infection
With the advent of MPLSM, immunologists are now able to
appreciate the complex and dynamic nature of an immune re-
sponse in unprecedented detail. Whilst previous reports had char-
acterised recruitment of inﬂammatory cells into the site of
infection using ﬂow cytometry and immunoﬂuorescence, we are
now able to examine the spatial and temporal nature of the re-
sponse to Leishmania infection.
Several reports have described the role of neutrophils in the
early response to experimental Leishmania infection following nee-
dle inoculation. Indeed, work by Tacchini-Cottier et al. demon-
strated the signiﬁcance of these cells, which are recruited within
an hour post-infection and, through early production of IL-12, are
associated with the resistance/susceptibility of different strains of
mice (Tacchini-Cottier et al., 2000). However, it is clear that sand
ﬂy biting is also associated with tissue damage and initiates a
strong inﬂammatory response, even in the absence of parasites
(Andrade et al., 2007). By using MPLSM to image the early response
to infection, Peters et al. visualised the migration of neutrophils in
mice expressing GFP under the lysozyme M promoter (Peters et al.,
2008). They demonstrated that following the sand ﬂy bite, neutro-
phils are rapidly recruited to the site of injury (irrespective of the
presence of parasites) and form a ‘‘plug” in order to close overthe hole left by the sand ﬂy proboscis. Subsequently, the fast-mov-
ing neutrophils migrate to the site of dermal infection, take up
Leishmania parasites by phagocytosis and reduce their migratory
capacity. Critically, despite phagocytosis, parasites remained viable
and transfer of infected neutrophils into naïve animals was able to
transfer infection which was associated with the transfer of para-
sites from neutrophils to macrophages. Hence, the initial uptake
of parasites by neutrophils may be important in the recruitment
and subsequent modulation of macrophages to provide the para-
site with an ideal host cell.
Concomitantly with recruitment of neutrophils from blood ves-
sels, dermal DCs begin to respond to Leishmania infection. Whilst
the early reports proposed a role for Langerhans cells in the re-
sponse to Leishmania infection (Moll et al., 1993), several recent re-
ports have suggested that (at least in L. major infection) these cells
are not necessary for the activation of CD4 T cell responses in the
draining lymph node (Lemos et al., 2004; Ritter et al., 2004). In-
stead, it has been suggested that activation of local dermal DCs
may be important in the induction of the adaptive immune re-
sponse (Ritter et al., 2004). Hence, a recent report by Ng et al.
investigated the in vivo response of Langerhans cells (LC) and der-
mal DCs (DDCs) following infection with L. major (Ng et al., 2008).
Using CD11c-YFP mice, the authors demonstrated that LC and
DDCs showed distinct behaviours in steady-state, with epidermal
LCs remaining relatively static but extending long dendrites to
effectively survey the microenvironment. Conversely, DDCs ac-
tively migrated through the interstitial space of naïve animals,
allowing them to rapidly detect and respond to infection. Thus,
within 20 min of L. major inoculation, DDCs decreased their migra-
tion and phagocytosed live parasites. Interestingly, this change in
behaviour was not restricted to DCs interacting with parasites, sug-
gesting that the localised inﬂammation alters DDC migratory
capacity rather than parasite uptake alone. How the migratory ar-
rest of these cells in the tissue correlates with migration to the
draining lymph node is unclear (Ritter et al., 2004), but may ex-
plain the relative importance of lymph node-resident DCs in anti-
gen-presentation in vivo (Iezzi et al., 2006).
As highlighted above, the application of MPLSM has provided an
insight into the interactions involved in the activation of naïve T cell
responses by antigen-presenting cells in the lymph node and en-
hanced our appreciation of the dynamic nature of naïve T cells (Mill-
er et al., 2002). Recent reports have investigated the behaviour of T
cells during a recall response in the lymph node following challenge
with either model antigen or Toxoplasma gondii (Chtanova et al.,
2009; Schaeffer et al., 2009; Wilson et al., 2009). However, the
behaviour of activated T cells in peripheral tissues has, until re-
cently, remained ill-deﬁned. The generation of transgenic mice
expressingaT cell receptor speciﬁcally recognising the LACKantigen
has allowed immunoparasitologists to examinemanyof the features
associated with the activation of Leishmania-speciﬁc adaptive
immunity (Reiner et al., 1998;Wanget al., 2001). Thus, Filipe-Santos
et al. have recently used these LACK-speciﬁc T cells to examine inter-
actionsbetweenactivatedT cells andparasite-containing cells in the
Leishmania lesion (Filipe-Santos et al., 2009). By imaging activated
CFSE-labelled LACK-speciﬁcWT15 CD4+ T cells as well as polyclonal
(labelled with both SNARF-1 and CFSE), it was demonstrated that
whilst activated T cells were recruited into the site of infection
non-speciﬁcally, only the parasite-speciﬁc T cells altered their
behaviour. The LACK-speciﬁc T cells were observed to slow down
and interact with some parasite-containing cells (identiﬁed by
DsRed-expressing L. major). Interestingly, not all infected cells were
able to attract T cells and areas containing a high density of parasites
were impenetrable to T cells.Whether this represents differences in
presentation of antigens, production of inﬂammatory cytokines or
chemokines, or simply physical constraints in the microenviron-
ment due to other (unseen) cells, remains to be established.
O.R. Millington et al. / Experimental Parasitology 126 (2010) 310–317 315NK cells have an important role in host protection. In addition
to their cytotoxicity role, recent evidence suggests an important
function of NK cells is in inﬂuencing DC function and T cell effector
responses (Ferlazzo et al., 2002; Gerosa et al., 2002; Piccioli et al.,
2002). By visualising the interactions between NK cells, DCs, and
T cells, Bajenoff et al. characterised an important role of early
NK-derived IFNc in directing the polarisation of CD4 T cell
response (Bajenoff et al., 2006). Using MPLSM, the authors demon-
strated that lymph node-resident NK cells are relatively slow-mov-
ing and establish long interactions with DCs even in the resting
state, but that following L. major infection, NK cells are recruited
to the paracortex of the lymph node and associate with parasite-
speciﬁc CD4 T cells and DCs. Thus, by imaging NK cell behaviour
in a Leishmania model, a potential role for these multi-cellular
interactions in inﬂuencing the immune response was identiﬁed.
The signiﬁcance of these NK cells in polarising a Th1 response in
this system remains to be identiﬁed, especially given the lack of
requirement for NK cells in Th1-mediated protection from L. major
infection (Satoskar et al., 1999).
3.4. Application of imaging approaches to developing therapeutics and
vaccines
Whilst the above reports have provided a fundamental under-
standing of the biology of Leishmania infection, imaging ap-
proaches have recently been used to analyse therapeutic and
vaccine candidates. A number of groups have used GFP or lucifer-
ase-expressing Leishmania to assess drug efﬁcacy in vitro, often
using rapid techniques such as ﬂow cytometry or microplate-based
bioluminescence (Dube et al., 2009). These approaches allow a
much higher throughput screening for investigating potential drug
candidates than conventional imaging, and GFP-expressing L. ma-
jor has been used to screen a large panel of extracts for effects on
parasite viability (Plock et al., 2001). Signiﬁcantly, the ability to
introduce GFP or luciferase expression in ﬁeld-isolates of L. dono-
vani allows in vitro screening of anti-leishmanial drugs (Ashutosh
et al., 2005; Singh and Dube, 2004).
Fluorescent and luminescent parasites are also being applied for
in vivo analysis of therapeutic and vaccine development. Using a
GFP-expressing L. amazonensis, Demicheli et al. showed that b-
cyclodextrin enhances the uptake of orally-delivered antimonials,
with signiﬁcantly reduced parasite loads (analysed ex vivo). Leco-
eur et al. demonstrated the feasibility of using luciferase-express-
ing bioluminescent L. major to assess topical therapeutics directly
in vivo (Lecoeur et al., 2007). Application of WR279396 (a recently
developed aminoglycoside formulation shown to be effective in
localised cutaneous leishmaniasis) to infection sites reduced the
bioluminescence signal and using whole-body imaging analysis
provided a more sensitive approach than conventional clinical
monitoring. In a similar approach, Mehta et al. used episomal
expression of GFP in L. amazonensis and analysed whole-body ﬂuo-
rescence to demonstrate the efﬁcacy of a vaccine candidate (Mehta
et al., 2008). Their work suggested that this approach provided an
increased sensitivity compared with standard approaches, as well
as providing real-time data on the distribution of infection.
Whilst we have focused here on imaging the interactions be-
tween the immune system and Leishmania parasites, several
groups have developed approaches for understanding the develop-
ment of parasites in the sandﬂy host. Thus, Kimblin et al. (2008) in-
fected sandﬂies with RFP-expressing L. major parasites and tracked
infection in ﬂies by imaging whole sandﬂies (Kimblin et al., 2008).
In Since Akopyants et al. (2009) have demonstrated genetic ex-
change between Leishmania major parasites in the sand ﬂy vector
(Akopyants et al., 2009), ﬂuorescent and bioluminescent markers
could also be used to track organisms of different lineages and
their genetic recombination, as has been shown with Trypanosoma(Peacock et al., 2009). These studies open new possibilities for
developing approaches to target parasites in the vector, rather than
in the mammalian host.
4. The future’s bright
Clearly the above approaches have provided a much greater
understanding of the fundamental biology of Leishmania infection
in the mouse, as well as starting to provide the potential for devel-
oping novel therapeutics and vaccines. The next step is for immu-
noparasitologists to dissect the many molecular pathways that are
important in each of these distinct stages of the immune response
and to establish their signiﬁcance in vivo. Obviously, many studies
have performed large-scale genomic/proteomic analyses or made
use of transgenic and knockout animals to understand the roles
of speciﬁc cytokines and receptors, as well as developing cell-spe-
ciﬁc expression/depletion mice to begin to understand the com-
plex (and often pleiotropic) roles of speciﬁc molecules in
infection. To fully comprehend the pathways involved we will need
to combine these approaches with imaging systems to assess the
distinct behaviour of speciﬁc cell types in these altered environ-
ments, or to use reporters of cell function in vivo. However, these
approaches pose some signiﬁcant challenges for biologists, chem-
ists, physicists and engineers. The methods described above have
distinct limitations in their ability to resolve less than several hun-
dred nanometres. Thus, application of new and emerging technol-
ogies providing resolution below the diffraction limit such as
stimulated emission depletion microscopy (STED (Willig et al.,
2006), photo-activated localisation microscopy (PALM (Betzig
et al., 2006)), stochastic optical reconstruction microscopy (STORM
(Rust et al., 2006)) and single molecule imaging (Funatsu et al.,
1995) will allow an illuminating insight into the interactions in-
volved in parasite uptake, survival and manipulation of the micro-
environment within the parasitophorous vacuole. In parallel,
development of novel ﬂuorochromes with emissions further into
the red allows improved in vivo imaging, with enhanced penetra-
tion of excitation and emission light and reduced autoﬂuorescence
(Lin et al., 2009; Shu et al., 2009). Critically, it will be important to
develop systems that provide the opportunity for a functional
read-out in vivo. Thus the developments of ﬂuorescent molecules
that can be switched on or off and/or change in colour in a con-
trolled way (Chudakov et al., 2004; Marchant et al., 2001) is of par-
ticular interest and combination of these developments with
transgenic/knockout/knockin animals will contribute to the ‘tool-
box’ available for future immunoparasitology studies. The ability
to directly manipulate the behaviour of a conscious animal by opti-
cally stimulating neurons highlights the incredible potential of
these approaches (Airan et al., 2009). Furthermore, the develop-
ment of alternative in vivo imaging approaches such as those based
on MRI, positron emission tomography (PET), Raman scattering or
microendoscopy provide the exciting possibility of visualising para-
site and cellular behaviourwithout the need for ﬂuorescent labels or
without theneed for surgical approaches. Critically, the combination
of multiple imaging approaches into one (e.g. Olson et al. (2010)),
alongwithother ﬁelds, such as genomics, proteomics andmetabolo-
mics,will provide theopportunity to identify keypathways thatmay
be useful for development of chemotherapeutics. As highlighted
above, imaging approaches are now being adapted for use in the
screening of candidate molecules, developing the capacity for the
high-throughput screening required if successful therapeutic and
vaccination strategies are to be developed further.
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